AlphAIAlphAI — Financial news for AI agents
StockNYSE · US · USDHealthcare · Health Information Services

$AMWL

American Well Corp

Price · $AMWLvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $AMWL in the last 7 days.

Insider · 30dAll trades →
Buys
—
0 txs
Sells
$261K
4 txs
McNeice Paul Francis1× · $8K
10b5-1 share of filings0%
See all $AMWL insider activity →
Top stories · $AMWLMore →
OCT 5·SEC EDGARLow

Zamansky Dmitry sold $110K of AMWL

Zamansky Dmitry (Chief Product & Tech. Officer) sold 8,442 shares of American Well Corp (AMWL) at $13.00 ($0.11M total) on 2026-10-01.

SEP 3·SEC EDGAR

HIRSCHHORN MARK sold $127K of AMWL

HIRSCHHORN MARK (Chief Financial Officer) sold 10,751 shares of American Well Corp (AMWL) at $11.80 ($0.13M total) on 2026-09-01.

AUG 12·fool.com

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.

AMWL sentiment & insider activity

Recent AMWL coverage spans market movers, insider activity and earnings.

In the last 30 days, AMWL insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($261K). The most active reporter was McNeice Paul Francis, Chief Accounting Officer, with 1 filing.

What's driving AMWL

  • The insider sale may signal modest concern and could weigh on the stock.

    SEC EDGAR · Oct 5, 2026

  • Insider sale by CFO may signal reduced confidence, but size is modest.

    SEC EDGAR · Sep 3, 2026

  • Guidance raises and a Defense Health Agency sole-source intent are likely to support near-term sentiment, but Q3 EBITDA loss guidance and churn keep risk elevated.

    fool.com · Aug 12, 2026

  • The trade is profitability improvement versus declining revenue, with Q3 guidance setting the near-term ceiling.

    rttnews.com · Aug 6, 2026

  • The article is a sell-side target revision story, not a fundamental company disclosure. It can still move near-term sentiment and positioning if traders treat PT changes as a proxy for improving outlook.

    tradingview.com · Aug 5, 2026

AlphAI scores every news story that mentions AMWL with an AI model for sentiment and relevance, and aggregates insider trades from American Well Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AMWL

Score
AUG 12$AMWLMedAI 8/10fool.com

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.

6 min read
AUG 6$ATTOMedrttnews.com

Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New High

Biotech stocks rose as several companies reported updates. Attovia Therapeutics (ATTO) jumped over 28% after its Nasdaq debut at $17 and a close at $21.90. American Well (AMWL) gained about 25% after Q2 loss narrowed to $9.6M, though revenue fell to $52.0M. Perrigo (PRGO) swung to Q2 net income of $74.5M. UroGen (URGN) rose after Q2 revenue increased to $72.5M.

3 min read
AUG 4$AMWLMedSEC EDGAR 8-K

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026 BOSTON, August 4 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026

4 min read
JUL 14$AMWLLowSEC EDGAR 8-K

American Well Corp (AMWL): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

American Well Corp (AMWL) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K 0001393584 false 0001393584 2026-07-08 2026-07-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 08,

2 min read
JUL 13$AMWLMedrttnews.com

Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH

Biotech stocks hit 52-week highs on July 10, 2026. American Well (AMWL) reached $10.16, citing Nature coverage of SilverCloud and insurer-related deals, and guided 2026 revenue to $195M-$205M. Cue Biopharma (CUE) hit $45.50 amid a ~$50M private placement. ImmuCell (ICCC) rose to $11.59 after Q2 sales of $7.2M. Scholar Rock (SRRK) hit $58.49 on BLA acceptance for apitegromab, with FDA response due by Sept. 30. Faeth (FTH) touched $36.89 on PIKTOR trial timelines.

5 min read
JUN 22$AMWLLowSEC EDGAR 8-K

American Well Corp (AMWL): Submission of Matters to a Vote of Security Holders

American Well Corp (AMWL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001393584 0001393584 2026-06-16 2026-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16,

2 min read

Related tickers

More in Health Information Services